Stay updated with breaking news from Nasdaq kzia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report) saw a large growth in short interest during the month of February. As of February 29th, there was short interest totalling 765,100 shares, a growth of 1,566.9% from the February 14th total of 45,900 shares. Based on an average daily volume of 680,600 shares, the days-to-cover ratio […] ....
Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report) dropped 8.9% during mid-day trading on Thursday . The stock traded as low as $0.38 and last traded at $0.40. Approximately 40,913 shares traded hands during mid-day trading, a decline of 34% from the average daily volume of 62,305 shares. The stock had previously closed at $0.44. […] ....
Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report) was the recipient of a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 113,400 shares, a growth of 1,889.5% from the October 31st total of 5,700 shares. Based on an average trading volume of 69,200 shares, […] ....
Kazia Therapeutics Limited (NASDAQ:KZIA – Get Free Report) was the target of a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 52,500 shares, an increase of 10.3% from the September 15th total of 47,600 shares. Based on an average trading volume of 39,300 shares, […] ....
Kazia Therapeutics (NASDAQ:KZIA – Get Free Report) and Arbutus Biopharma (NASDAQ:ABUS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership. Earnings and Valuation This table compares Kazia […] ....